MedTrace Logo

Development and Pilot Testing of the Sense2Quit App

NCT05609032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-11-06

Study results available
· View outcomes & findings →

Summary

This is a pilot randomized controlled trial to examine the feasibility, acceptability and preliminary efficacy of the Sense2Quit App in a sample of 60 PLWH who smoke.

Conditions

  • Smoking Cessation
  • HIV Infections

Interventions

BEHAVIORAL

Sense2Quit App

Participants in the intervention arm will receive access to Sense2Quit, a smartphone app that links to a smartwatch.

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Rebecca Schnall, PhD, MPH · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-06
Primary Completion
2024-01-12
Completion
2024-01-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05609032 on ClinicalTrials.gov